Ophthalmic Bevacizumab Reaches Critical Review Stage In EU

 
• By Neena Brizmohun
  
3D illustration of BEVACIZUMAB title on a medical document
The EMA is reviewing a marketing application for an ophthalmic formulation of bevacizumab • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards